# Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients

> **NCT06852625** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Fundacion Clinic per a la Recerca Biomédica** · enrollment: 30 (estimated)

## Conditions studied

- Kidney Transplant Rejection

## Interventions

- **BIOLOGICAL:** Autologous Tolerogenic Dendritic Cells

## Key facts

- **NCT ID:** NCT06852625
- **Lead sponsor:** Fundacion Clinic per a la Recerca Biomédica
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-05
- **Primary completion:** 2028-03
- **Final completion:** 2028-03
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06852625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06852625, "Autologous Tolerogenic Dendritic Cells (ATDC) for Highly Sensitized Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT06852625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*